Associated Papers
Genetic variants underlying precancerous conditions of hepatocellular carcinoma.
Guerrero JJG et al.
International Journal of Cancer, 2026
Current Diagnosis and Management of Familial Hypobetalipoproteinemia 1.
Wakabayashi T et al.
Journal of Atherosclerosis and Thrombosis, 2024
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics.
Huang G et al.
Biomedicines, 2023
Update on the molecular biology of dyslipidemias.
Ramasamy I
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2016
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Dongiovanni P et al.
World Journal of Gastroenterology, 2014
Exome sequencing: new insights into lipoprotein disorders.
Farhan SM et al.
Current Cardiology Reports, 2014
Hypobetalipoproteinemia and abetalipoproteinemia.
Welty FK
Current Opinion in Lipidology, 2014
Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.
Zhang Y et al.
Plos One, 2014
A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia.
Cefalù AB et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2013
The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.
Di Leo E et al.
Journal of Clinical Lipidology, 0
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.
Di Costanzo A et al.
Journal of Clinical Lipidology, 0
Select a paper to view details